{"address1": "259 Liberty Avenue", "city": "Staten Island", "state": "NY", "zip": "10305", "country": "United States", "phone": "917 533 1469", "website": "https://www.acurxpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert J. DeLuccia", "age": 78, "title": "Co-Founder & Executive Chairman", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 818930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David P. Luci CPA, Esq., J.D.", "age": 57, "title": "Co-Founder, President, CEO, Corporate Secretary & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 786883, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert G. Shawah CPA", "age": 57, "title": "Co-Founder & CFO", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 533653, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.39, "open": 0.396, "dayLow": 0.375, "dayHigh": 0.396, "regularMarketPreviousClose": 0.39, "regularMarketOpen": 0.396, "regularMarketDayLow": 0.375, "regularMarketDayHigh": 0.396, "payoutRatio": 0.0, "beta": -1.706, "forwardPE": -0.24470969, "volume": 151358, "regularMarketVolume": 151358, "averageVolume": 365766, "averageVolume10days": 144670, "averageDailyVolume10Day": 144670, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 8360720, "fiftyTwoWeekLow": 0.375, "fiftyTwoWeekHigh": 3.325, "fiftyDayAverage": 0.63664, "twoHundredDayAverage": 1.4897, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 4654011, "profitMargins": 0.0, "floatShares": 19357072, "sharesOutstanding": 22042500, "sharesShort": 423814, "sharesShortPriorMonth": 213358, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0195, "heldPercentInsiders": 0.116689995, "heldPercentInstitutions": 0.098000005, "shortRatio": 0.86, "shortPercentOfFloat": 0.0219, "impliedSharesOutstanding": 22443700, "bookValue": 0.036, "priceToBook": 10.536112, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -14103103, "trailingEps": -0.87, "forwardEps": -1.55, "52WeekChange": -0.8105, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.3793, "targetHighPrice": 12.0, "targetLowPrice": 1.5, "targetMeanPrice": 6.6975, "targetMedianPrice": 6.645, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 3706713, "totalCashPerShare": 0.168, "totalDebt": 0, "quickRatio": 1.159, "currentRatio": 1.19, "returnOnAssets": -1.52406, "returnOnEquity": -5.34026, "freeCashflow": -5094767, "operatingCashflow": -10383431, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ACXP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Acurx Pharmaceuticals, Inc.", "corporateActions": [], "regularMarketTime": 1743537601, "exchange": "NCM", "messageBoardId": "finmb_558025934", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -0.25734, "fiftyDayAverageChangePercent": -0.4042159, "twoHundredDayAverageChange": -1.1104, "twoHundredDayAverageChangePercent": -0.745385, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-25", "prevName": "Acurx Pharmaceuticals, LLC", "nameChangeDate": "2025-04-01", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1624627800000, "regularMarketChange": -0.010699987, "regularMarketDayRange": "0.375 - 0.396", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 365766, "fiftyTwoWeekLowChange": 0.0042999983, "fiftyTwoWeekLowChangePercent": 0.011466662, "fiftyTwoWeekRange": "0.375 - 3.325", "fiftyTwoWeekHighChange": -2.9457002, "fiftyTwoWeekHighChangePercent": -0.8859249, "fiftyTwoWeekChangePercent": -81.05, "earningsTimestamp": 1742295662, "earningsTimestampStart": 1747139400, "earningsTimestampEnd": 1747657800, "earningsCallTimestampStart": 1742299200, "earningsCallTimestampEnd": 1742299200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.87, "epsForward": -1.55, "epsCurrentYear": -0.845, "priceEpsCurrentYear": -0.44887573, "longName": "Acurx Pharmaceuticals, Inc.", "regularMarketChangePercent": -2.7435865, "regularMarketPrice": 0.3793, "displayName": "Acurx Pharmaceuticals", "trailingPegRatio": null}